Literature DB >> 9669438

Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma.

M F Gadallah1, Y Kayyas, F Boules.   

Abstract

Reduced adrenocortical (aldosterone and cortisol) and adrenomedullary (adrenaline) secretory mass after unilateral adrenalectomy for aldosterone-producing adenoma has been associated with long-term hypotension (more than 2 years) in some studies. In these patients, cortisol and aldosterone levels are low, whereas plasma renin activity is high. Other studies suggest that normotension and normal plasma renin activity and serum aldosterone and cortisol levels are achieved in 60% to 87% of the patients without evidence of decreased adrenal mass, whereas the remaining patients may continue to have hypertension. We report a unique case in which unilateral adrenalectomy for adrenal adenoma was followed by severe hyperkalemia, marked volume depletion and undetectable plasma renin activity, and serum aldosterone, suggesting marked, chronic suppression of the renin-aldosterone axis. One year later, a gradual return to normokalemia, normotension, and normal plasma renin activity and aldosterone levels was achieved, indicating resolution of the suppression of the renin-aldosterone axis. Patients undergoing unilateral adrenalectomy for aldosteronoma should be followed up closely after unilateral adrenalectomy of adrenal adenoma to avoid life-threatening hyperkalemia and severe intravascular volume depletion.

Entities:  

Mesh:

Year:  1998        PMID: 9669438     DOI: 10.1053/ajkd.1998.v32.pm9669438

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Aldosterone deficiency after unilateral adrenalectomy for Conn's syndrome: a case report and literature review.

Authors:  Ekua Yorke; Sara Stafford; Daniel Holmes; Sachiv Sheth; Adrienne Melck
Journal:  Int J Surg Case Rep       Date:  2015-01-10

2.  Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.

Authors:  Yatsuka Hibi; Nobuki Hayakawa; Midori Hasegawa; Kimio Ogawa; Yoshimi Shimizu; Masahiro Shibata; Chikara Kagawa; Yutaka Mizuno; Yukio Yuzawa; Mitsuyasu Itoh; Katsumi Iwase
Journal:  Surg Today       Date:  2013-12-17       Impact factor: 2.549

3.  Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series.

Authors:  A Tahir; K McLaughlin; G Kline
Journal:  BMC Endocr Disord       Date:  2016-07-27       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.